| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,903 |
37,355 |
$3.70M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13,326 |
12,066 |
$1.34M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,394 |
11,106 |
$1.22M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,237 |
7,813 |
$1.03M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,171 |
8,687 |
$960K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,378 |
5,105 |
$618K |
| 90686 |
|
15,085 |
13,961 |
$323K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,016 |
6,189 |
$312K |
| D1206 |
Topical application of fluoride varnish |
12,076 |
11,901 |
$297K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
27,633 |
24,818 |
$263K |
| 90698 |
|
9,164 |
8,152 |
$190K |
| 92551 |
|
18,108 |
16,951 |
$166K |
| 90670 |
|
7,566 |
6,743 |
$159K |
| 99381 |
|
1,619 |
1,345 |
$145K |
| 90680 |
|
5,939 |
5,297 |
$123K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,790 |
4,899 |
$117K |
| 90633 |
|
5,023 |
4,513 |
$105K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
937 |
842 |
$103K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,624 |
2,133 |
$101K |
| 90744 |
|
4,629 |
4,142 |
$97K |
| 92587 |
|
3,857 |
3,486 |
$86K |
| 90710 |
|
3,656 |
3,338 |
$78K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,874 |
3,216 |
$77K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,926 |
3,603 |
$67K |
| 90651 |
|
2,725 |
2,543 |
$59K |
| 99173 |
|
21,229 |
19,787 |
$52K |
| 99070 |
|
7,981 |
6,410 |
$46K |
| 54150 |
|
813 |
630 |
$43K |
| 90677 |
|
1,491 |
1,301 |
$43K |
| 99460 |
|
600 |
513 |
$43K |
| 83655 |
|
4,688 |
4,120 |
$42K |
| 99383 |
|
375 |
337 |
$42K |
| 0071A |
|
1,050 |
989 |
$39K |
| 0072A |
|
949 |
926 |
$37K |
| 96127 |
|
8,194 |
7,678 |
$37K |
| 90696 |
|
1,600 |
1,512 |
$35K |
| 90619 |
|
1,021 |
898 |
$34K |
| 90621 |
|
1,480 |
1,373 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,003 |
2,573 |
$32K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
571 |
486 |
$30K |
| 90715 |
|
1,349 |
1,260 |
$30K |
| 99051 |
|
4,479 |
3,722 |
$29K |
| 96161 |
|
11,995 |
10,677 |
$28K |
| 90734 |
|
1,217 |
1,174 |
$27K |
| 0002A |
|
679 |
669 |
$26K |
| 0001A |
|
675 |
651 |
$26K |
| 99382 |
|
175 |
160 |
$20K |
| 99384 |
|
142 |
127 |
$18K |
| 97802 |
|
195 |
159 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
456 |
385 |
$16K |
| 86580 |
|
2,836 |
2,418 |
$15K |
| 90480 |
|
438 |
382 |
$14K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
451 |
402 |
$13K |
| 85018 |
|
7,098 |
6,330 |
$12K |
| 90380 |
|
109 |
50 |
$12K |
| 91321 |
|
238 |
200 |
$12K |
| 90381 |
|
96 |
55 |
$11K |
| 99215 |
Prolong outpt/office vis |
77 |
71 |
$10K |
| 0124A |
|
352 |
243 |
$10K |
| 91320 |
|
179 |
165 |
$10K |
| 0081A |
|
225 |
178 |
$7K |
| 90661 |
|
334 |
327 |
$7K |
| 0003A |
|
173 |
162 |
$6K |
| 0154A |
|
208 |
163 |
$6K |
| 0073A |
|
147 |
127 |
$5K |
| 91319 |
|
82 |
76 |
$4K |
| 90716 |
|
197 |
181 |
$4K |
| 90707 |
|
193 |
173 |
$4K |
| 0111A |
|
121 |
100 |
$4K |
| 0004A |
|
103 |
99 |
$4K |
| 91318 |
|
58 |
51 |
$3K |
| 0082A |
|
81 |
72 |
$3K |
| 0151A |
|
114 |
86 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
292 |
159 |
$3K |
| 3008F |
|
3,655 |
3,330 |
$3K |
| 80061 |
Lipid panel |
241 |
216 |
$2K |
| 90691 |
|
27 |
20 |
$2K |
| 99000 |
|
8,693 |
7,007 |
$2K |
| 81002 |
|
858 |
786 |
$2K |
| 0121A |
|
51 |
45 |
$2K |
| 0112A |
|
49 |
35 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
171 |
125 |
$1K |
| 92015 |
Determination of refractive state |
38 |
36 |
$696.10 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
47 |
44 |
$645.42 |
| 90713 |
|
29 |
27 |
$582.00 |
| 36416 |
|
6,204 |
4,618 |
$469.77 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
81 |
68 |
$414.80 |
| 94760 |
|
204 |
166 |
$308.52 |
| 90687 |
|
16 |
13 |
$264.50 |
| 3011F |
|
216 |
198 |
$201.50 |
| 36415 |
Collection of venous blood by venipuncture |
108 |
103 |
$164.39 |
| 91307 |
|
1,183 |
1,013 |
$133.02 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
33 |
32 |
$84.13 |
| 81025 |
|
13 |
13 |
$82.28 |
| A7015 |
Aerosol mask, used with dme nebulizer |
33 |
32 |
$72.74 |
| 91312 |
|
258 |
166 |
$36.05 |
| 91308 |
|
179 |
134 |
$36.03 |
| 91315 |
|
317 |
250 |
$1.95 |
| 91311 |
|
243 |
177 |
$1.55 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
13 |
$1.32 |
| 91317 |
|
98 |
63 |
$0.61 |
| 91300 |
|
943 |
838 |
$0.59 |
| 91314 |
|
153 |
32 |
$0.25 |
| 99402 |
|
64 |
45 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
65 |
49 |
$0.00 |